Placebo-controlled, randomized, double-blind study on the efficacy of bone-marrow stem cell mobilization induced by granulocyte-colony stimulating factor (G-CSF) on improvement of ischemic heart failure undergoing delayed revascularization for ST segment elevation myocardial infarction (STEMI)

被引：0
|
作者：
Engelmann, MG
Theiss, H
Wintersperger, B
Schönberg, S
Franz, WM
机构：
[1] Univ Munich, Dept Med 1, Munich, Germany
[2] Univ Munich, Dept Diagnost Radiol, Munich, Germany
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2829
引用
收藏
页码：622 / 622
页数：1
相关论文
共 29 条
  • [21] Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial
    Achilli, Felice
    Malafronte, Cristina
    Lenatti, Laura
    Gentile, Francesco
    Dadone, Viola
    Gibelli, Giuseppe
    Maggiolini, Stefano
    Squadroni, Lidia
    Di Leo, Claudio
    Burba, Ilaria
    Pesce, Maurizio
    Mircoli, Luca
    Capogrossi, Maurizio C.
    Di Lelio, Alessandro
    Camisasca, Paola
    Morabito, Alberto
    Colombo, Gualtiero
    Pompilio, Giulio
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (10) : 1111 - 1121
  • [22] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOID CANCER - AN ECONOMIC-ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    LUCE, BR
    SINGER, JW
    WESCHLER, JM
    BUCKNER, CD
    SHEINGOLD, SH
    SHANNONDORCY, K
    APPELBAUM, FR
    NEMUNAITIS, J
    PHARMACOECONOMICS, 1994, 6 (01) : 42 - 48
  • [23] Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
    DiPersio, John F.
    Micallef, Ivana N.
    Stiff, Patrick J.
    Bolwell, Brian J.
    Maziarz, Richard T.
    Jacobsen, Eric
    Nademanee, Auayporn
    McCarty, John
    Bridger, Gary
    Calandra, Gary
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4767 - 4773
  • [24] Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI)
    Abbate, Antonio
    Van Tassell, Benjamin
    Bogin, Vlad
    Markley, Roshanak
    Pevzner, Dmitry V.
    Cremer, Paul C.
    Meray, Imad
    Privalov, Dmitry V.
    Taylor, Angela
    Grishin, Sergey A.
    Egorova, Alina N.
    Ponomar, Ekaterina G.
    Lavrovsky, Yan
    Samsonov, Mikhail Yu
    CIRCULATION, 2024, 150 (07) : 580 - 582
  • [25] Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction: A Multicenter Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
    Fernandez-Aviles, Francisco
    Sanz-Ruiz, Ricardo
    Bogaert, Jan
    Casado Plasencia, Ana
    Gilaberte, Inmaculada
    Belmans, Ann
    Eugenia Fernandez-Santos, Maria
    Charron, Dominique
    Mulet, Miguel
    Yotti, Raquel
    Palacios, Itziar
    Luque, Manuel
    Sadaba, Rafael
    Alberto San Roman, J.
    Larman, Mariano
    Sanchez, Pedro L.
    Sanchis, Juan
    Jimenez, Manuel F.
    Claus, Piet
    Al-Daccak, Reem
    Lombardo, Eleuterio
    Luis Abad, Jose
    DelaRosa, Olga
    Corcostegui, Lucia
    Bermejo, Javier
    Janssens, Stefan
    CIRCULATION RESEARCH, 2018, 123 (05) : 579 - 589
  • [26] Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy
    Trachtenberg, Barry
    Velazquez, Darcy L.
    Williams, Adam R.
    McNiece, Ian
    Fishman, Joel
    Nguyen, Kim
    Rouy, Didier
    Altman, Peter
    Schwarz, Richard
    Mendizabal, Adam
    Oskouei, Behzad
    Byrnes, John
    Soto, Victor
    Tracy, Melissa
    Zambrano, Juan Pablo
    Heldman, Alan W.
    Hare, Joshua M.
    AMERICAN HEART JOURNAL, 2011, 161 (03) : 487 - 493
  • [27] Mouth-washings with recombinant human granulocyte–macrophage colony stimulating factor (rhGM-CSF) do not improve grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study
    D Valcárcel
    MA Sanz
    A Sureda
    M Sala
    L Muñoz
    M Subirá
    R Laborda
    A Clopés
    J Sierra
    Bone Marrow Transplantation, 2002, 29 : 783 - 787
  • [28] Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation.: Results of a randomized double-blind placebo-controlled study
    Valcárcel, D
    Sanz, MA
    Sureda, A
    Sala, M
    Muñoz, L
    Subirá, M
    Laborda, R
    Clopés, A
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2002, 29 (09) : 783 - 787
  • [29] Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
    Chakrabarti, Anjan K.
    Feeney, Kristin
    Abueg, Cassandra
    Brown, David A.
    Czyz, Ewa
    Tendera, Michal
    Andras Janosi
    Giugliano, Robert P.
    Kloner, Robert A.
    Weaver, W. Douglas
    Bode, Christoph
    Godlewski, Jacek
    Bela Merkely
    Gibson, C. Michael
    AMERICAN HEART JOURNAL, 2013, 165 (04) : 509 - +
123